NDI
Venture capitalCleveland · Seed–Series A · 14 people tracked
Investment thesis
NDI invests exclusively in innovative neurodevice technologies designed to restore lost neurological function, prevent neurological damage, and reduce the painful effects of disease and injury. As a hybrid venture capital and commercialization firm, it provides capital to identify and develop technologies, launch and grow companies, and take them through to successful exits.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directoriesWhat they invest in
from 3 of 4 portfolio companiesHealthtech ×3Medical Devices ×2Biotech ×1Hardware ×1
HQs:United States×3
Investments · 4 tracked
founders shown can be your intro pathBy year:2019 · 12015 · 12 dated
SPR is a medical device company that develops the SPRINT Peripheral Nerve Stimulation (PNS) System, a non-opioid, non-surgical, minimally invasive treatment for acute and chronic pain.
HardwareHealthtechMedical DevicesCleveland, US
Maria Bennett(President, CEO & Founder)inJosh Boggs(Executive Officer)inMark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)Ben Austin(Chief Financial Officer)inDavid Youngberg(Chief Commercial Officer)
Board seatGeoffrey B. Thrope· per SEC Form D
Co-investorsJumpstart VenturesMutual Capital PartnersRC CapitalRevelation PartnersRiver Cities Capital
Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery.
BiotechHealthtechMedical DevicesCleveland, US
Marilyn A. Eisele(Executive Officer)Kevin M. Scanlan(Executive Officer)Donald Hubbard(Executive Officer)inMark Stultz(Executive Officer)
BoardTracy Marshbanks(Director)inGeoffrey B. Thrope(Executive Officer, Director)in
Co-investorsFirst AnalysisJumpstart VenturesMutual Capital PartnersRC Capital
HealthtechCleveland, US
Leonard Cosentino(Executive Officer, Director)
BoardWarren M. Grill(Executive Officer, Director)Geoffrey B. Thrope(Executive Officer, Director)in
Peripheral nerve stimulation system for multiple pain management indications.
Frequently asked questions
- What stage does NDI invest at?
- NDI invests at the Seed, Series A stages.
- What sectors does NDI focus on?
- NDI focuses on Biotech, Hardware, Healthtech, Medical Devices.
- Where is NDI located?
- NDI is headquartered in Cleveland, US.
- Who does NDI co-invest with?
- NDI most often shares deals with Jumpstart Ventures, Mutual Capital Partners, RC Capital, among 4 tracked co-investors.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Excell Partners manages a state-supported fund in partnership with the University of Rochester and New York State, offering pre-seed and seed stage capital to early-stage technology companies in Upstate New York.














.jpeg)